期刊文献+

上皮性卵巢癌组织中miRNA-21a/b表达及其临床意义 被引量:4

Expression of miRNA-21a/b in Patients with Epithelial Ovarian Cancer Tissues and Its Clinical Significance
下载PDF
导出
摘要 目的探讨上皮性卵巢癌(epithelial ovarian cancer,EOC)组织中miRNA-21a/b的表达及其临床意义。方法选择卵巢癌病理组织标本88例,其中EOC组织标本68例(EOC组),良性卵巢上皮性肿瘤组织标本20例(良性组)。取所有患者手术切除的病灶组织样本,采用q PCR法检测miRNA-21a/b表达水平,调查所有患者的临床病理资料并进行相关性分析。结果EOC组的miRNA-21a、miRNA-21b相对表达水平都显著高于良性组(P<0.05)。随着临床分期的增加、组织学分化的降低以及淋巴结转移,EOC患者的miRNA-21a/b相对表达水平显著增加(P<0.05)。在EOC患者中,直线相关分析显示患者的miRNA-21a/b相对表达水平与临床分期、组织学分化、淋巴结转移成显著正相关性(P<0.05)。COX回归分析显示临床分期、组织学分化、淋巴结转移都为影响EOC组织miRNA-21a/b相对表达水平的主要因素(P<0.05)。结论EOC患者组织miRNA-21a/b呈现高表达状态,与患者的临床分期、组织学分化、淋巴结转移显著相关。 Objective To investigate the expression of miRNA-21 a/b in patients with epithelial ovarian cancer(EOC tissues and its clinical significance.Methods 88 patients with pathological tissue specimens from obstetrics and gynecology were selected that included patients of 68 EOC tissue specimens(EOC group)and 20 patients of benign ovarian epithelial tumor tissue specimens(benign group).The tissue samples of all the patients were removed,and the expression level of miRNA-21 a/b were detected by q PCR.The clinical and pathological data of all patients were investigated and given correlation analysis.Results The relative expression levels of miRNA-21 a and miRNA-21 b in the EOC group were significantly higher than those in the benign group(P<0.05).The relative expression levels of miRNA-21 a/b in the EOC patients were increased significantly with increased clinical stage,decreased histological differentiation,and lymph node metastasis(P<0.05).In the EOC patients,linear correlation analysis showed that patients’relative expression levels of miRNA-21 a/b was significantly positively correlated with clinical stage,histological differentiation,and lymph node metastasis(P<0.05).COX regression analysis showed that clinical stage,histological differentiation,and lymph node metastasis were the main factors affected the relative expression levels of miRNA-21 a/b in the EOC tissues(P<0.05).Conclusion The expression of miRNA-21 a/b in tissues of EOC patients is highly correlated with clinical staging,histological differentiation and lymph node metastasis.
作者 王清芬 甄静 李君 WANG Qingfen;ZHEN Jing;LI Jun(The Second People's Hospital of Xinxiang,Xinxiang,453002)
出处 《实用癌症杂志》 2020年第7期1098-1101,共4页 The Practical Journal of Cancer
基金 2018年河南省医学科技攻关计划项目(编号:2018010049)。
关键词 上皮性卵巢癌 miRNA-21a miRNA-21b 病理特征 相关性 Epithelial ovarian cancer miRNA-21a miRNA-21b Pathological features Correlation
  • 相关文献

参考文献7

二级参考文献28

  • 1Yan-Ni Xi,Xiao-Yan Xin,Hong-Mei Ye.Effects of HMGA2 on malignant degree,invasion,metastasis,proliferation and cellular morphology of ovarian cancer cells[J].Asian Pacific Journal of Tropical Medicine,2014,7(4):289-292. 被引量:7
  • 2Mei L, Chen H, Wei DM, et al. Maintenance chemotherapy for ovarian cancer[J]. Cochrane Database Syst Rev, 2013, 6: CD007414. DOI: 10.1002/14651858.CD007414.pub3.
  • 3Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells[J]. Cancer Res, 2005, 65(14):6029-6033. DOI: 10.1158/0008-5472. CAN-05-0137.
  • 4Si ML, Zhu S, Wu H, et al. miR-21-mediated tumor growth[J]. Oncogene, 2007, 26(19):2799-2803. DOI: 10.1038/sj. onc.1210083.
  • 5Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer[J]. Oncogene, 2008, 27(15): 2128-2136. DOI: 10.1038/sj.onc.1210856.
  • 6Lou Y, Yang X, Wang F, et al. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein[J]. Int J Mol Med, 2010,26(6):819-827.
  • 7Bourguignon LY, Spevak CC, Wong G, et al. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells[J]. J Biol Chem, 2009,284(39):26533-26546. DOI: 10.1074/jbc. M 109.027466.
  • 8Hwang JH, Voortman J, Giovannetti E, et al. Identification ofmicroRNA-21 as a biomarker tbr chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer[J]. PLoS One, 2010,5(5):e10630. DOI: 10.1371/journal. pone.0010630.
  • 9Lou Y, Cui Z, Wang F, et al. miR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells[J]. Clin Invest Med, 2011,34(5): E281.
  • 10Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer[J]. Apoptosis, 2004,9(6): 667-676. DOI: 10.1023/B:APPT.0000045801.15585.dd.

共引文献52

同被引文献40

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部